Atsena Therapeutics and Nippon Shinyaku Enter Exclusive License Agreement for ATSN-101
Atsena Therapeutics Inc., a UF Startup, has entered into an exclusive license agreement with Nippon Shinyaku Co., Ltd. for the commercialization of ATSN-101 in the United States, and for its development and commercialization in Japan.
Scientists Trained AI To Detect Faces in Pain. In Goats.
UF researchers fed data on goats' facial expressions into an AI-based model, enabling it to distinguish goats in pain by their faces alone. With data on more goats and other animal species, such AI models may help clinicians effectively treat pain in patients who cannot communicate verbally.
Seeding the Future: UF/IFAS and Florida Sea Grant Secure $250K NOAA Grant To Cultivate Seaweed Aquaculture in Florida
The University of Florida and Florida Sea Grant have secured a $250,000 grant from NOAA to investigate seaweed aquaculture cultivated from Florida’s tropical waters, aiming to boost the state’s economy while benefiting its environment and coastal communities.
Innovative Molekule Air Purifiers Now Available at Crate & Barrel
UF startup Molekule announced that its air purifiers are now available for purchase online at Crate & Barrel, expanding consumer reach and accessibility.
Genascence Granted FDA Fast Track Designation for GNSC-001 in Patients With Osteoarthritis (OA) of the Knee
UF Startup Genascence Corporation announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) for GNSC-001, a potential first-in-class gene therapy for the treatment of patients with osteoarthritis (OA) of the knee.
United Nations Ratifies UF-Created Framework To Protect People on Cash Apps
UF researcher Kevin Butler developed the framework, which spells out guidance for countries to prevent fraud and abuse on mobile cash apps.
With an NIH Pioneer Award, UF Researcher Targets Common Infection
UF researcher Ivana Parker is targeting one of the most common and dangerous infections in women, backed by a $2.7 million grant from the National Institutes of Health.
Solid Biosciences Shares Updates on Inspire Duchenne Clinical Trial of SGT-003
Solid Biosciences, a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases that acquired UF startup AavantiBio, shared updates on the INSPIRE DUCHENNE clinical trial for their next-generation AAV micro-dystrophin gene therapy candidate, SGT-003, for the treatment of Duchenne.
Space Florida Announces Launch of Florida University Space Consortium
Space Florida’s Board of Directors designated the Florida University Space Research Consortium, as the state’s official space research entity, which will facilitate the awarding of NASA research grants in partnership with Kennedy Space Center.
The Wertheim UF Scripps Institute, UF Medicinal Chemistry Target Incurable Diseases
University of Florida researchers with expertise in drug discovery and chemistry are advancing potential treatments for challenging diseases via a new collaborative initiative.
